Literature DB >> 29632167

Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.

Ralf G Rempe1, Anika M S Hartz2,3, Emma L B Soldner4, Brent S Sokola1, Satya R Alluri1, Erin L Abner2, Richard J Kryscio2,5, Anton Pekcec4, Juli Schlichtiger4, Björn Bauer6,7.   

Abstract

The blood-brain barrier is dysfunctional in epilepsy, thereby contributing to seizure genesis and resistance to antiseizure drugs. Previously, several groups reported that seizures increase brain glutamate levels, which leads to barrier dysfunction. One critical component of barrier dysfunction is brain capillary leakage. Based on our preliminary data, we hypothesized that glutamate released during seizures mediates an increase in matrix-metalloproteinase (MMP) expression and activity levels, thereby contributing to barrier leakage. To test this hypothesis, we exposed isolated brain capillaries from male Sprague Dawley rats to glutamate ex vivo and used an in vivo/ex vivo approach of isolated brain capillaries from female Wistar rats that experienced status epilepticus as an acute seizure model. We found that exposing isolated rat brain capillaries to glutamate increased MMP-2 and MMP-9 protein and activity levels, and decreased tight junction protein levels, which resulted in barrier leakage. We confirmed these findings in vivo in rats after status epilepticus and in brain capillaries from male mice lacking cytosolic phospholipase A2 Together, our data support the hypothesis that glutamate released during seizures signals an increase in MMP-2 and MMP-9 protein expression and activity levels, resulting in blood-brain barrier leakage.SIGNIFICANCE STATEMENT The mechanism leading to seizure-mediated blood-brain barrier dysfunction in epilepsy is poorly understood. In the present study, we focused on defining this mechanism in the brain capillary endothelium. We demonstrate that seizures trigger a pathway that involves glutamate signaling through cytosolic phospholipase A2, which increases MMP levels and decreases tight junction protein expression levels, resulting in barrier leakage. These findings may provide potential therapeutic avenues within the blood-brain barrier to limit barrier dysfunction in epilepsy and decrease seizure burden.
Copyright © 2018 the authors 0270-6474/18/384301-15$15.00/0.

Entities:  

Keywords:  Blood-Brain barrier; MMP; barrier dysfunction; barrier leakage; cPLA2

Mesh:

Substances:

Year:  2018        PMID: 29632167      PMCID: PMC5932641          DOI: 10.1523/JNEUROSCI.2751-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

2.  Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy.

Authors:  Linda Holtman; Erwin A van Vliet; Peter M Edelbroek; Eleonora Aronica; Jan A Gorter
Journal:  Epilepsy Res       Date:  2010-09       Impact factor: 3.045

3.  Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.

Authors:  Nicola Marchi; Qingshan Teng; Chaitali Ghosh; Qingyuan Fan; Minh T Nguyen; Nirav K Desai; Harpreet Bawa; Peter Rasmussen; Thomas K Masaryk; Damir Janigro
Journal:  Brain Res       Date:  2010-06-27       Impact factor: 3.252

4.  Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures.

Authors:  Audrey P Le; Wilma J Friedman
Journal:  J Neurosci       Date:  2012-01-11       Impact factor: 6.167

5.  Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy.

Authors:  C L Wilson; N T Maidment; M H Shomer; E J Behnke; L Ackerson; I Fried; J Engel
Journal:  Epilepsy Res       Date:  1996-12       Impact factor: 3.045

6.  Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy.

Authors:  Nagisa Sada; Suni Lee; Takashi Katsu; Takemi Otsuki; Tsuyoshi Inoue
Journal:  Science       Date:  2015-03-20       Impact factor: 47.728

7.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

Authors:  Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla
Journal:  Brain Res       Date:  2010-03-01       Impact factor: 3.252

8.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

Authors:  E A van Vliet; S da Costa Araújo; S Redeker; R van Schaik; E Aronica; J A Gorter
Journal:  Brain       Date:  2006-11-22       Impact factor: 13.501

9.  Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling.

Authors:  Y Ueda; N Tsuru
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045

10.  Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.

Authors:  Taura L Barr; Lawrence L Latour; Kyung-Yul Lee; Timothy J Schaewe; Marie Luby; George S Chang; Ziad El-Zammar; Shaista Alam; John M Hallenbeck; Chelsea S Kidwell; Steven Warach
Journal:  Stroke       Date:  2009-12-24       Impact factor: 7.914

View more
  33 in total

1.  cPLA2 in Epilepsy: Shutting Down the Leaker at Its Source.

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

2.  Materials for blood brain barrier modeling in vitro.

Authors:  Magali P Ferro; Sarah C Heilshorn; Roisin M Owens
Journal:  Mater Sci Eng R Rep       Date:  2020-01-06       Impact factor: 36.214

3.  Epilepsy and Alterations of the Blood-Brain Barrier: Cause or Consequence of Epileptic Seizures or Both?

Authors:  Wolfgang Löscher
Journal:  Handb Exp Pharmacol       Date:  2022

4.  The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

Authors:  Diede Wm Broekaart; Alexandra Bertran; Shaobo Jia; Anatoly Korotkov; Oleg Senkov; Anika Bongaarts; James D Mills; Jasper J Anink; Jesús Seco; Johannes C Baayen; Sander Idema; Elodie Chabrol; Albert J Becker; Wytse J Wadman; Teresa Tarragó; Jan A Gorter; Eleonora Aronica; Roger Prades; Alexander Dityatev; Erwin A van Vliet
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 5.  Neuroinflammation after surgery: from mechanisms to therapeutic targets.

Authors:  Ting Yang; Ravikanth Velagapudi; Niccolò Terrando
Journal:  Nat Immunol       Date:  2020-10-19       Impact factor: 25.606

Review 6.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

7.  Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Authors:  Arpna Srivastava; Jyotirmoy Banerjee; Vivek Dubey; Manjari Tripathi; P Sarat Chandra; M C Sharma; Sanjeev Lalwani; Fouzia Siraj; Ramesh Doddamani; Aparna Banerjee Dixit
Journal:  Cell Mol Neurobiol       Date:  2020-11-28       Impact factor: 5.046

8.  Increased hippocampal excitability in miR-324-null mice.

Authors:  Dan J Hayman; Tamara Modebadze; Sarah Charlton; Kat Cheung; Jamie Soul; Hua Lin; Yao Hao; Colin G Miles; Dimitra Tsompani; Robert M Jackson; Michael D Briggs; Katarzyna A Piróg; Ian M Clark; Matt J Barter; Gavin J Clowry; Fiona E N LeBeau; David A Young
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 9.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

10.  Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy.

Authors:  Anika M S Hartz; Ralf G Rempe; Emma L B Soldner; Anton Pekcec; Juli Schlichtiger; Richard Kryscio; Bjoern Bauer
Journal:  FASEB J       Date:  2019-10-29       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.